Joan Maurel

14PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersRadiation therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 28, 2026
Immune-Metabolic Profiling Reveals Functional Heterogeneity Within Colorectal Cancer Consensus Molecular Subtypes.

|Jun 19, 2026
Studying When to Add Biological Therapy to Cytotoxic Therapy in Advanced Cancer Care Using Real World Data: How to Avoid Design Choices That Generate Immortal Time.

|May 18, 2026
EXONERATE-TRaCE: A Liquid Biopsy for Tracking Response to Anti-Epidermal Growth Factor Receptor-Based Therapy in Metastatic Colorectal Cancer.

|Mar 28, 2026
Genetic Variants Associated with Fluoropyrimidine-Induced Toxicity in Real-World Patients After Pre-Emptive DPYD Pharmacogenetic Testing.

María Rodríguez-García, Sara Salvador-Martín, Mariam Stephanie Rojas Piedra

|Nov 10, 2025
circ-EGFR is a predictor of response to Cetuximab and a potential target in colorectal cancer.

Silei Sui, Yuan Li, Joan Maurel

|Sep 29, 2025
Metabolic plasticity drives specific mechanisms of chemotherapy and targeted therapy resistance in metastatic colorectal cancer.

Mariam Rojas, Malena Manzi, Sergio Madurga

Pageof 3

Frequent Collaborators

3 joint publications

Silvia Marin

3 joint publications

Ajay Goel

3 joint publications

Sergio Madurga

3 joint publications

Marta Cascante